Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View


Denali Therapeutics Announces Initiation Of Phase 1b Study Of EIF2B Activator DNL343 in ALS


Benzinga | Sep 9, 2021 09:04AM EDT

Denali Therapeutics Announces Initiation Of Phase 1b Study Of EIF2B Activator DNL343 in ALS






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC